HER2 Support Group Forums - View Single Post

Andrea Barnett Budin · 11-03-2007, 01:53 PM

DR. DENNIS SLAMON, M.D. PhD., Chief of the Division of Hematology/Oncology, regarded as a leading expert in the field of bc. His work in this disease over the past two decades led to the identification of HER-3 position bc as a distinct subtype of aggressive disease and ultimately to the development of the new drug Herceptin. An internet link to access a profile on Dr. Slamon -- at UCLA HEALTHCARE/HEMATOLOY-ONCOLOGY:

htt://www.healthcare.ucla.edu/insitution/physician?personnel id =8232

PATIENT SERVICES AT UCLA -- 1 - 888 - 662 - 8252.

************************************************** *****

DR. MARK PEGRAM, M.D. can be contacted at the University of Miami, Sylvester Compreshensive Cancer Center -- 305) 243 - 4909.

In a letter I received this past June from Dr. Pegram (as a previous patient) -- he also recommends colleagues remaining at UCLA: Dr. Sara Hurvitz (a leader in the UCLA BC Program), Dr. Saeed Sadeghi (actively involved in clinical trials in bc), Dr. John Glaspy (internationally recognized expert in bc).

11-03-2007, 01:53 PM	#3
Andrea Barnett Budin Senior Member Join Date: Oct 2005 Location: LAND OF YES! w/home in Boca Raton, Florida Orig from L.I., N.Y. Ever hovering IN THE NOW... Posts: 1,904	Drs. Slamon, Pegram... DR. DENNIS SLAMON, M.D. PhD., Chief of the Division of Hematology/Oncology, regarded as a leading expert in the field of bc. His work in this disease over the past two decades led to the identification of HER-3 position bc as a distinct subtype of aggressive disease and ultimately to the development of the new drug Herceptin. An internet link to access a profile on Dr. Slamon -- at UCLA HEALTHCARE/HEMATOLOY-ONCOLOGY: htt://www.healthcare.ucla.edu/insitution/physician?personnel id =8232 PATIENT SERVICES AT UCLA -- 1 - 888 - 662 - 8252. ************************************************ * DR. MARK PEGRAM, M.D. can be contacted at the University of Miami, Sylvester Compreshensive Cancer Center -- 305) 243 - 4909. In a letter I received this past June from Dr. Pegram (as a previous patient) -- he also recommends colleagues remaining at UCLA: Dr. Sara Hurvitz (a leader in the UCLA BC Program), Dr. Saeed Sadeghi (actively involved in clinical trials in bc), Dr. John Glaspy (internationally recognized expert in bc). __________________ Andi BB** '95 post-meno dx Invasive LOBULAR w/9cm tumor! YIKES + 2/21 nodes. Clear mammo 10 mnths earlier. Mastec/tram flap reconst/PORT/8 mnths chemo (4Adria/8CMF). Borderline ER/PR. Tamoxifen 2 yrs. Felt BLESSED. I could walk and talk, feed and bathe myself! I KNEW I would survive... '98 -- multiple mets to liver. HER2+ 80%. ER/PR- Raging, highly aggressive tumors spreading fast. New PORT. 9 mnths Taxotere Fought fire w/fire! Pronounced in cautious remission 5/99. Taxotere weekly for 6 wks, 2 wks off -- for 9 mnths. TALK ABOUT GRUELING! (I believe they've altered that protocol since those days -- sure hope so!!) + good old Vit H wkly for 1st 3 yrs, then triple dosage ev 3 wks for 7 yrs more... The "easy" chemo, right?! Not a walk in the park, but not a freight train coming at 'ya either... Added Herceptin Nov '98 (6 wks after FDA fast-tracked it for met bc). Stayed w/Vit H till July '08! Now I AM FREE! Humbly and eternally grateful for this life-saving drug! NED since '99 and planning on keeping it that way. To hell w/poor prognosis and nasty stats! STOPPED VIT H JULY '08...! REMAIN STABLE... Eternally grateful...Yes is a world & in this world of yes live (skillfully curled) all worlds ... (e e cummings) EVERY DAY I BEAT MY PREVIOUS RECORD FOR # OF CONSECUTIVE DAYS I'VE STAYED ALIVE. Smile KNOWING you too can be a miracle. Up to me and God now...